Heterocyclic Anticancer Agents / / ed. by Bimal Krishna Banik, Bubun Banerjee.

• Superior document: Title is part of eBook package: De Gruyter DG Plus DeG Package 2022 Part 1
• MitwirkendeR: Al Matarneh, Cristina Maria,; Amariucai-Mantu, Dorina,; Antoci, Vasilichia,; Bandopadhyay, Tania,; Banerjee, Bubun,; Basha, Jeelan N.,; Basu, Amartya,; Chawla, Pooja A.,; Danac, Ramona,; Das, Aparna,; Faleiros da Silva Maia, Angélica,; Freitas Rego, Yuri de,; Fátima, Ângelo de,; Goel, Nidhi,; Gunavanthrao Yernale, Nagesh,; Karmakar, Rajiv,; Kaur, Gurpreet,; Kaur, Mandeep,; Kaur, Manmeet,; Kaur, Manmmet,; Kiran Misra, Shashi,; Krishna Banik, Bimal,; Kumar Gangasani, Jagadees,; Kumar, Naresh,; Kumar, Sunil,; Majhi, Sasadhar,; Mangalagiu, Ionel,; Martins de Lacerda, Rodrigo,; Modi Naidu, Vegi Ganga,; Morais Costa, Nathália Evelyn,; Moreira da Silva, Cleiton,; Mukhopadhyay, Chhanda,; Pathak, Devender,; Pathak, Kamla,; Patil, Madhuri T.,; Priya, Anu,; Rao Vaidya, Jayathirtha,; Salunke, Deepak B.,; Sardaru, Monica Cornelia,; Sharma, Aditi,; Singh, Arvind,; Suliphuldevara Matada, Basavarajaiah,; Wahan, Simranpreet K.,; Yarasi, Siwaswarup,
• HerausgeberIn: Banerjee, Bubun,; Krishna Banik, Bimal,
• Place / Publishing House: Berlin ;, Boston : : De Gruyter, , [2022]; ©2022
• Year of Publication: 2022
• Language: English
• Physical Description: 1 online resource (XX, 512 p.)

Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties tha...

Table of Contents

• Frontmatter
• Preface
• Contents
• List of contributing authors
• 1 Naturally occurring, natural product inspired and synthetic heterocyclic anti-cancer drugs
• 2 Naturally occurring heterocyclic anticancer compounds
• 3 Lawsone (2-hydroxy-1,4-naphthaquinone) derived anticancer agents
• 4 Advances in heterocycles as DNA intercalating cancer drugs
• 5 Recent advances of heterocycle based anticancer hybrids
• 6 Fused pyrrolo-pyridines and pyrrolo-(iso) quinoline as anticancer agents
• 7 Updates on the versatile quinoline heterocycles as anticancer agents
• 8 Recent development of imidazole derivatives as potential anticancer agents
• 9 Recent developments in the synthesis and anti-cancer activity of acridine and xanthine-based molecules
• 10 Synthesis of new horizons in benzothiazole scaffold and used in anticancer drug development
• 11 Triazine based chemical entities for anticancer activity
• 12 Anticancer properties of arylchromenes and arylchromans: an overview
• 13 Anticancer potential of indole derivatives: an update
• 14 Indole based prostate cancer agents
• Index